# Changing Pattern of HDV Infection in Italy Over 40 Years; the Current Scenario and the Impending Challenge

**Authors:** Gian Paolo Caviglia, Tommaso Stroffolini

PMC · DOI: 10.1111/jvh.70172 · Journal of Viral Hepatitis · 2026-03-17

## TL;DR

HDV infection in Italy has declined due to vaccination but is increasing among migrants, creating new medical challenges.

## Contribution

The paper documents the changing epidemiology and clinical features of HDV in Italy over 40 years, emphasizing the impact of migration.

## Key findings

- HDV prevalence has declined in native Italians due to HBV vaccination.
- Migratory flows are reintroducing HDV into Italy, increasing infection rates among migrants.
- New clinical patterns, including indolent phenotypes, are emerging.

## Abstract

Since the initial description of HDV, in the last four decades Italy has witnessed a profound decline of the infection driven by HBV vaccination, contrasted however by the reconstitution of a viral reservoir through migratory flows from endemic HDV areas; in parallel, the medical scenario has changed, resulting in different clinical outcomes. The epidemiological and clinical changes were documented by national surveys performed up to 2025, which provided an ongoing perspective on the long‐term evolution of HDV, highlighting the temporal trends in prevalence, risk factors, and clinical features. This review summarises the changes over time of HDV in Italy and the contemporary epidemiologic features of an infection that is vanishing among natives but increasing among migrants, outlining the medical challenge of a new heterogeneous clinical spectrum, including indolent phenotypes.

## Linked entities

- **Diseases:** HDV (MONDO:0005789)

## Full-text entities

- **Diseases:** HD (MESH:D006816), CHD (MESH:D019701), HCC (MESH:D006528), cirrhotic (MESH:D000094724), death (MESH:D003643), chronic infection (MESH:D000088562), HIV-infected (MESH:D015658), HBV hepatitis (MESH:D006509), IVDU (MESH:D015819), HDV Infection (MESH:D007239), HDV (MESH:D003699), liver cirrhosis (MESH:D008103), liver decompensation (MESH:D017093), liver disease (MESH:D008107), chronic active hepatitis (MESH:D006521), cirrhosis (MESH:D005355), hepatitis (MESH:D056486), viral hepatitis (MESH:D014777)
- **Chemicals:** bulevirtide (MESH:C000718249)
- **Species:** Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus 1 (no rank) [taxon 11676], Human immunodeficiency virus (species) [taxon 12721], Meleagris gallopavo (common turkey, species) [taxon 9103], hepatitis C virus [taxon 11103], Hepatitis delta virus (no rank) [taxon 12475]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12993911/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12993911/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12993911/full.md

---
Source: https://tomesphere.com/paper/PMC12993911